a new era in OUTPATIENT CARE

Haugh, Richard
June 2000
H&HN: Hospitals & Health Networks;Jun2000, Vol. 74 Issue 6, p44
Trade Publication
Focuses on the outpatient prospective payment system (PPS) launched by Medicare on July 1, 2000. Obstacles faced by hospitals regarding the outpatient PPS; Opportunity that could be offered by the switch to outpatient PPS in overall operations; Key to success with outpatient PPS according to experts. INSETS: Who wins? Who loses? Who knows?;The Hey: Get doctors to cooperate.


Related Articles

  • New outpatient PPS means big changes for all hospitals. Cassil, Alwyn // AHA News;09/14/98, Vol. 34 Issue 36, p1 

    Focuses on the proposed Medicare outpatient prospective-payment system (PPS) in the United States. Major redistribution effects of the rule; Comments from Linda Magno of the American Hospitals Association (AHA); Terms under the proposed outpatient PPS rule. INSET: Highlights of AHA concerns...

  • Repeal the $1,500 Caps.  // ASHA Leader;9/10/2002, Vol. 7 Issue 16, p27 

    Emphasizes the need for U.S. citizens to convince their senators to repeal the Medicare therapy caps. Effect of the caps on speech-language pathology and physical therapy outpatient services that are reimbursed under Medicare Part B for an entire year; Negative effect of the caps on...

  • Complex outpatient cases, prompt pay among priorities. Brown, Steve // AHA News;04/16/2001, Vol. 37 Issue 15, p1 

    Discusses the policy agenda of the American Hospital Association related to the failure of the Medicare provider payment system (PPS) for out-patient cases in the United States in 2001. Discrepancies associated to PPS implementation in 1998; Payment returns received by health providers from...

  • implementing the MMA. Wilensky, Gail R. // hfm (Healthcare Financial Management);Jun2004, Vol. 58 Issue 6, p30 

    Examines challenges faced by the United States Centers for Medicare and Medicaid Services (CMS) related to the implementation of the Medicare Prescription Drug, Improvement, and Modernization Act. Encouragement of private plan participation in Medicare; Changes to Part B outpatient drug...

  • CMS Clarifies Rural Status for Transnational Outpatient Payments.  // hfm (Healthcare Financial Management);Jun2004, Vol. 58 Issue 6, p10 

    Reports that the United States Centers for Medicare and Medicaid Services has clarified rural-hospital status for transitional outpatient payments. Conditions that make a hospital have the rural status; Extension of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 to...

  • OPPS advances in minute steps as available prep time rushes by. Webb, Craig // AHA News;06/19/2000, Vol. 36 Issue 24, p1 

    Focuses on the issues raised in relation to the launching of Medicare's Outpatient Prospective Payment System (OPPS) in the United States as of June 2000. Impact of OPPS on the decision of the Health Care Financing Administration (HCFA) to back off from a plan to limit rural hospitals; Rural...

  • Medicare bundles medications into ESRD payments. Thompson, Cheryl A. // American Journal of Health-System Pharmacy;10/1/2010, Vol. 67 Issue 19/20, p1580 

    The article reports that hospitals are likely to receive higher payments for rendering outpatient maintenance dialysis services to Medicare beneficiaries with end-stage renal disease (ESRD). The U.S. Centers for Medicare and Medicaid Services (CMS) says that the so-called bundled payment system...

  • Quick Hits: Top News Stories of the Month.  // hfm (Healthcare Financial Management);Apr2010, Vol. 64 Issue 4, p18 

    The article offers news briefs related to healthcare financial management in the U.S. The Medicare Payment Advisory Commission (MedPAC) has recommended the Congress to increase acute inpatient and outpatient prospective payment systems (PPS) rates by 2011. The Kaiser Family Foundation has stated...

  • CMS keeps 2010 OPPS drug reimbursement rate at ASP plus 4%. Traynor, Kate // American Journal of Health-System Pharmacy;12/15/2009, Vol. 66 Issue 24, p2154 

    The article discusses the plan of the U.S. Centers for Medicare and Medicaid Services (CMS) to keep drug reimbursement rate of the outpatient prospective payment system (OPPS) at average sales price (ASP) plus 4% in 2010. Justine Coffey of the American Society of Health-System Pharmacists (ASHP)...

  • CMS Issues Ruling on Retisert.  // Review of Ophthalmology;Nov2005, Vol. 12 Issue 11, p11 

    Reports that Bausch & Lomb Inc.'s single-indication orphan drug Retisert that is compose of fluocinolone acetonide intravitreal implant has been approved by the Centers for Medicare & Medicaid to be eligible for Medicare Hospital Outpatient Prospective Payment System effective October 1, 2005 in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics